The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Myocardial infarction, commonly known as a heart attack, is one of the most serious heart problems people can face. It ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...

Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Acute myocardial infarction is an event of myocardial necrosis caused by an unstable ischemic syndrome. 1 In practice, the disorder is diagnosed and assessed on the basis of clinical evaluation ...

Acute myocardial infarction can be triggered by acute respiratory infections. Previous studies have suggested an association between influenza and acute myocardial infarction, but those studies use ...

The analysis of post–acute myocardial infarction mortality did not attempt to demonstrate a causal relationship between the acute myocardial infarction care and survival, as several clinical ...